Literature DB >> 82483

Protein synthesis by rat transplantable yolk sac tumor and its relation to the cytosol levels of translatable messenger RNA's.

Y Kaneko, Y Endo, T Oda.   

Abstract

alpha-Fetoprotein (AFP) was shown to be the major secretory protein produced in vitro by normal rat yolk sacs. While not so active, AFP production was also detected in the transplantable tumors derived from normal yolk sacs. The major secretory protein synthesized by the tumor cells had a molecular weight of 40,000 and was reactive with an anti-rat albumin antibody. The functional messenger RNA's coding for these proteins were quantitated by translation in a cell-free system derived from wheat germ followed by specific immunoprecipitation of the newly synthesized peptides. The overall template activity of the RNA prepared from the normal yolk sacs and yolk sac tumor cells was virtually identical. The cytosol RNA prepared from the normal yolk sacs was approximately 12 times more active than that from the tumor cells in directing the synthesis of AFP. The presence of the cytosol RNA prepared from the tumor cells was required for the synthesis of proteins immunoprecipitable with the antialbumin antibody. These results suggest that the changes in AFP and albumin synthesis can be accounted for by a corresponding change in the levels of functional messenger RNA's coding for these proteins.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 82483

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  3 in total

1.  Synthesis of serum proteins by the posthaematopoietic feline yolk sac.

Authors:  K Tiedemann; W W Minuth
Journal:  Histochemistry       Date:  1980

2.  the pig yolk sac II. Analysis of synthesized proteins.

Authors:  W W Minuth; K Tiedemann
Journal:  Histochemistry       Date:  1980

3.  Effects of sodium n-butyrate on alpha-fetoprotein and albumin secretion in the human hepatoma cell line PLC/PRF/5.

Authors:  T Nakagawa; Y Nakao; T Matsui; T Koizumi; S Matsuda; S Maeda; T Fujita
Journal:  Br J Cancer       Date:  1985-03       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.